# Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy

> **NCT01520324** · PHASE2 · COMPLETED · sponsor: **Cosmo Technologies Ltd** · enrollment: 53 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DEVICE:** oral delivery mucosal stain

## Key facts

- **NCT ID:** NCT01520324
- **Lead sponsor:** Cosmo Technologies Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2019-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01520324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01520324, "Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01520324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*